Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

NCT00967057 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

470

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: asparaginase
DRUG: dexamethasone
DRUG: idarubicin
DRUG: methotrexate
DRUG: mitoxantrone hydrochloride
DRUG: pegaspargase
DRUG: vincristine sulfate

Sponsor

Children's Cancer and Leukaemia Group